Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticles

Molecular Imaging

Volumn 10, Issue 1, 2011, Pages 43-55

  Serda, Rita E ^a,b,c,d,e   Blanco, Elvin ^a,b,c,d,e   Mack, Aaron ^a,b,c,d,e   Stafford, Susan J ^a,b,c,d,e   Amra, Sarah ^a,b,c,d,e   Li, Qingpo ^a,b,c,d,e   Van, Anne De Ven ^a,b,c,d,e   Tanaka, Takemi ^a,b,c,d,e   Torchilin, Vladimir P ^a,b,c,d,e   Wiktorowicz, John E ^a,b,c,d,e   Ferrari, Mauro ^a,b,c,d,e  

^a UNIVERSITY OF TEXAS   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Rice University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIODISTRIBUTIONS; CELLULAR ASSOCIATION; CELLULAR INTERACTION; DRUG DELIVERY VEHICLES; IMMUNOHISTOCHEMISTRY; MASS TRANSPORT; MICRO-PARTICLES; PARTICLE PROPERTIES; PARTICLE SURFACE; PROTEOMIC ANALYSIS; SCANNING ELECTRON MICROGRAPHS; SELECTIVE BINDING; SERUM PROTEINS; SURFACE RECEPTORS; TWO-DIMENSIONAL GEL ELECTROPHORESIS;

BODY FLUIDS; DRUG DELIVERY; ELECTROPHORESIS; ENDOTHELIAL CELLS; LIVER; MACROPHAGES; MASS SPECTROMETRY; POROUS SILICON; PROTEINS; SCANNING ELECTRON MICROSCOPY; SELF ASSEMBLY; SURFACE CHEMISTRY; TWO DIMENSIONAL;

DYES;

DRUG CARRIER; OPSONIN; SILICON;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; MASS SPECTROMETRY; METABOLISM; MOUSE; POROSITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; DRUG CARRIERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; MASS SPECTROMETRY; MICE; OPSONIN PROTEINS; POROSITY; SILICON;

EID: 79951870272     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2011.00008     Document Type: Article

References (25)

1. Ferrari M. Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends Biotechnol 2010;28: 181-8.
2. Sakamoto J, Annapragada A, Decuzzi P, Ferrari M. Antibiological barrier nanovector technology for cancer applications. Expert Opin Drug Deliv 2007;4:359-69, doi:10.1517/17425247.4.4.359. (Pubitemid 47249137)
3. Decuzzi P, Godin B, Tanaka T, et al. Size and shape effects in the biodistribution of intravascularly injected particles. J Control Release 2010;141:320-7.
4. Gentile F, Ferrari M, Decuzzi P. The transport of nanoparticles in blood vessels: the effect of vessel permeability and blood rheology. Ann Biomed Eng 2008;36:254-61, doi:10.1007/s10439-007-9423-6.
5. Campbell RB, Fukumura D, Brown EB, et al. Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors. Cancer Res 2002;62: 6831-6. (Pubitemid 35424069)
6. Walczyk D, Bombelli FB, Monopoli MP, et al. What the cell "sees" in bionanoscience. J Am Chem Soc 2010;132:5761-8, doi:10.1021/ ja910675v.
7. Tasciotti E, Liu X, Bhavane R, et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat Nanotechnol 2008;3:151-7, doi:10.1038/nnano. 2008.34. (Pubitemid 351355132)
8. Chiappini C, Tasciotti E, Fakhoury JR, et al. Tailored porous silicon microparticles: fabrication and properties. Chemphyschem 2010;11:1029-35.
9. Hashizume H, Baluk P, Morikawa S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-80. (Pubitemid 30660013)
10. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-21.
11. Lopez MF, Berggren K, Chernokalskaya E, et al. A comparison of silver stain and SYPRO Ruby protein gel stain with respect to protein detection in two dimensional gels and identification by peptide mass profiling. Electrophoresis 2000;21:3673-83, doi:10.1002/1522-2683(200011)21:17,3673::AID-ELPS3673.3.0. CO;2-M.
12. Zhang W, Chait BT. ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Analyt Chem 2000;72:2482-9, doi:10.1021/ac991363o. (Pubitemid 30395651)
13. Brasier AR, Spratt H, Wu Z, et al. Nuclear heat shock response and novel nuclear domain 10 reorganization in respiratory syncytial virus-infected A549 cells identified by high-resolution twodimensional gel electrophoresis. J Virol 2004;78:11461-76, doi:10.1128/JVI.78.21.11461-11476.2004. (Pubitemid 39390734)
14. Serda RE, Mack A, Pulikkathara M, et al. Cellular association and assembly of a multistage delivery system. Small 2010;6:1329-40, doi:10.1002/smll.201000126.
15. Serda RE, Gu J, Bhavane RC, et al. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. Biomaterials 2009;30:2440-8, doi:10.1016/j.biomaterials. 2009.01.019.
16. Liu Y, Ibricevic A, Cohen JA, et al. Impact of hydrogel nanoparticle size and functionalization on in vivo behavior for lung imaging and therapeutics. Mol Pharm 2009;6:1891-902, doi:10.1021/ mp900215p.
17. Thurston G, McLean JW, Rizen M, et al. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest 1998;101:1401-13, doi:10.1172/JCI965. (Pubitemid 28166838)
18. Krasnici S, Werner A, Eichhorn ME, et al. Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer 2003;105:561-7, doi:10.1002/ijc.11108. (Pubitemid 36578564)
19. Rejinold NS, Muthunarayanan M, Deepa N, et al. Development of novel fibrinogen nanoparticles by two-step co-acervation method. Int J Biol Macromol 2010;47:37-43, doi:10.1016/j.ijbiomac. 2010.03.023.
20. Kaul M, Loos M. The Fc-recognizing, collagen-like C1q molecule is a putative type II membrane protein of macrophages. Behring Inst Mitt 1993;93:171-9.
21. Lundqvist M, Stigler J, Elia G, et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A 2008;105:14265-70, doi:10.1073/pnas.0805135105.
22. Gaubatz JW, Ghanem KI, Guevara J Jr, et al. Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. J Lipid Res 1990;31:603-13. (Pubitemid 20167627)
23. Rall SC Jr, Weisgraber KH, Innerarity TL, et al. Identification of a new structural variant of human apolipoprotein E, E2(Lys146 leads to Gln), in a type III hyperlipoproteinemic subject with the E3/2 phenotype. J Clin Invest 1983;72:1288-97, doi:10.1172/JCI111085. (Pubitemid 13013761)
24. Datta G, Chaddha M, Garber DW, et al. The receptor binding domain of apolipoprotein E, linked to a model class A amphipathic helix, enhances internalization and degradation of LDL by fibroblasts. Biochemistry 2000;39:213-20, doi:10.1021/bi991209w. (Pubitemid 30033336)
25. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003;100:9440-5, doi:10.1073/ pnas.1530509100. (Pubitemid 37033947)